+111.1%
DINO vs GSK
+31.2%
+79.9%
-17.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.7% | -1.9% | +1.2% | -1.1% |
| 7D | +5.7% | -1.8% | +7.5% | +5.3% |
| 30D | +27.8% | -2.2% | +30.0% | +27.3% |
| 3M | +45.6% | -1.8% | +47.4% | +45.3% |
| 6M | +88.5% | -10.6% | +99.1% | +86.6% |
| YTD | +134.1% | +4.4% | +129.7% | +127.2% |
| 1Y | +111.1% | +30.4% | +80.7% | +104.7% |
| All | +111.1% | +31.2% | +79.9% | +104.7% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling